Medical Developments International Limited
Medical Developments International Limited manufactures and distributes emergency medical solutions in Australia, Asia, Europe, the United States, and internationally. The company operates through Pain Management and Respiratory segments. It offers Penthrox, a trauma and emergency pain relief product for use in hospitals, emergency departments, ambulance services, sport medicines, and for analges… Read more
Medical Developments International Limited (MDDVF) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2025: 0.013x
Based on the latest financial reports, Medical Developments International Limited (MDDVF) has a cash flow conversion efficiency ratio of 0.013x as of June 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($709.00K) by net assets ($55.10 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Medical Developments International Limited - Cash Flow Conversion Efficiency Trend (2004–2025)
This chart illustrates how Medical Developments International Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Medical Developments International Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Medical Developments International Limited ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
EBQLF
PINK:EBQLF
|
N/A |
|
C3 Metals Inc
OTCQB:CUAUF
|
-0.012x |
|
Halmont Properties Corporation
V:HMT
|
0.002x |
|
Grupo Concesionario del Oeste SA
BA:OEST
|
0.033x |
|
Atrium Real Estate Investment Trust
KLSE:5130
|
0.125x |
|
Pontex Polyblend Co.Ltd
TWO:8935
|
0.039x |
|
Vakrangee Limited
NSE:VAKRANGEE
|
0.093x |
|
QUADFUTURE
NSE:QUADFUTURE
|
0.020x |
Annual Cash Flow Conversion Efficiency for Medical Developments International Limited (2004–2025)
The table below shows the annual cash flow conversion efficiency of Medical Developments International Limited from 2004 to 2025.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-06-30 | $55.10 Million | $-43.00K | -0.001x | +99.67% |
| 2024-06-30 | $45.73 Million | $-10.78 Million | -0.236x | -16.20% |
| 2023-06-30 | $81.31 Million | $-16.50 Million | -0.203x | -8.40% |
| 2022-06-30 | $57.30 Million | $-10.72 Million | -0.187x | -45.11% |
| 2021-06-30 | $68.30 Million | $-8.81 Million | -0.129x | -1029.90% |
| 2020-06-30 | $43.34 Million | $601.00K | 0.014x | -97.09% |
| 2019-06-30 | $44.59 Million | $21.27 Million | 0.477x | +460.77% |
| 2018-06-30 | $21.04 Million | $1.79 Million | 0.085x | -54.19% |
| 2017-06-30 | $21.60 Million | $4.01 Million | 0.186x | -70.72% |
| 2016-06-30 | $19.02 Million | $12.07 Million | 0.634x | +228.69% |
| 2015-06-30 | $17.41 Million | $3.36 Million | 0.193x | +135.79% |
| 2014-06-30 | $15.82 Million | $1.29 Million | 0.082x | +31.75% |
| 2013-06-30 | $15.73 Million | $977.00K | 0.062x | -68.60% |
| 2012-06-30 | $16.17 Million | $3.20 Million | 0.198x | -5.67% |
| 2011-06-30 | $14.46 Million | $3.03 Million | 0.210x | +47.18% |
| 2010-06-30 | $12.71 Million | $1.81 Million | 0.142x | +31.08% |
| 2009-06-30 | $11.81 Million | $1.28 Million | 0.109x | +4.45% |
| 2008-06-30 | $11.80 Million | $1.23 Million | 0.104x | -9.48% |
| 2007-06-30 | $11.02 Million | $1.27 Million | 0.115x | -1.48% |
| 2006-06-30 | $9.87 Million | $1.15 Million | 0.117x | +72.27% |
| 2005-06-30 | $8.40 Million | $569.00K | 0.068x | +41.46% |
| 2004-06-30 | $8.37 Million | $401.00K | 0.048x | -- |